These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 19559158)

  • 21. Increased fracture risk and osteoporosis not associated with vitamin D levels in Malaysian patients with inflammatory bowel disease.
    Hilmi I; Sunderesvaran K; Ananda V; Sarji SA; Arumugam K; Goh KL
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2415-21. PubMed ID: 23553858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Etiopathogenesis, diagnostics and treatment of osteoporosis at inflammatory bowel diseases].
    Eksp Klin Gastroenterol; 2005; (3):8-14, 100. PubMed ID: 16255547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nutrients in the Prevention of Osteoporosis in Patients with Inflammatory Bowel Diseases.
    Ratajczak AE; Rychter AM; Zawada A; Dobrowolska A; Krela-Kaźmierczak I
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32517239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of bone mineral density in inflammatory bowel disease: current safety focus.
    Lichtenstein GR
    Am J Gastroenterol; 2003 Dec; 98(12 Suppl):S24-30. PubMed ID: 14697915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone mineral density evaluation by physicians in patients with inflammatory bowel disease: differences based on corticosteroid use.
    Thanjan AJ; Tishon JR; Borum ML
    Am J Gastroenterol; 2006 Nov; 101(11):2669-70. PubMed ID: 17090293
    [No Abstract]   [Full Text] [Related]  

  • 26. Managing osteoporosis in ulcerative colitis: something new?
    Piodi LP; Poloni A; Ulivieri FM
    World J Gastroenterol; 2014 Oct; 20(39):14087-98. PubMed ID: 25339798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment.
    Katz S
    Rev Gastroenterol Disord; 2006; 6(2):63-71. PubMed ID: 16699475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Widely differing screening and treatment practice for osteoporosis in patients with inflammatory bowel diseases in the Swiss IBD cohort study.
    Schüle S; Rossel JB; Frey D; Biedermann L; Scharl M; Zeitz J; Freitas-Queiroz N; Kuntzen T; Greuter T; Vavricka SR; Rogler G; Misselwitz B;
    Medicine (Baltimore); 2017 Jun; 96(22):e6788. PubMed ID: 28562531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Osteoporosis and inflammatory bowel disease].
    Menchén L; Ripoll C; Bretón I; Moreno C; de la Cuerda C; Camblor M; García-Peris P; González-Lara V; Cos E
    Nutr Hosp; 2005; 20(1):26-37. PubMed ID: 15762417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
    Tan B; Li P; Lv H; Li Y; Wang O; Xing XP; Qian JM
    J Dig Dis; 2014 Mar; 15(3):116-23. PubMed ID: 24354597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoporosis and Psoriasis.
    Muñoz-Torres M; Aguado P; Daudén E; Carrascosa JM; Rivera R
    Actas Dermosifiliogr (Engl Ed); 2019 Oct; 110(8):642-652. PubMed ID: 31151668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Examination for osteoporosis in patients with chronic obstructive pulmonary disease].
    Johansen NJ; Harsløf T; Hermann AP; Andersen CU; Hilberg O; Løkke A
    Ugeskr Laeger; 2018 Oct; 180(40):. PubMed ID: 30274583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perspectives on osteoporosis in pediatric inflammatory bowel disease.
    Harpavat M; Keljo DJ
    Curr Gastroenterol Rep; 2003 Jun; 5(3):225-32. PubMed ID: 12734045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention and treatment of osteoporosis in inflammatory bowel disease.
    Lichtenstein GR; Sands BE; Pazianas M
    Inflamm Bowel Dis; 2006 Aug; 12(8):797-813. PubMed ID: 16917235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
    Vestergaard P
    Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride.
    Abitbol V; Mary JY; Roux C; Soulé JC; Belaiche J; Dupas JL; Gendre JP; Lerebours E; Chaussade S;
    Aliment Pharmacol Ther; 2002 May; 16(5):919-27. PubMed ID: 11966500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease.
    Valentine JF; Sninsky CA
    Am J Gastroenterol; 1999 Apr; 94(4):878-83. PubMed ID: 10201450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone Health in Patients With Inflammatory Bowel Diseases.
    Chedid VG; Kane SV
    J Clin Densitom; 2020; 23(2):182-189. PubMed ID: 31375349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D deficiency and corticosteroid use are risk factors for low bone mineral density in inflammatory bowel disease patients.
    Abraham BP; Prasad P; Malaty HM
    Dig Dis Sci; 2014 Aug; 59(8):1878-84. PubMed ID: 24619280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis: cost-utility analysis using a Markov model.
    Kreck S; Klaus J; Leidl R; von Tirpitz C; Konnopka A; Matschinger H; König HH
    Pharmacoeconomics; 2008; 26(4):311-28. PubMed ID: 18370566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.